Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 Feb 24;312(7029):458–459. doi: 10.1136/bmj.312.7029.458

Flavonoids and heart disease.

M F Muldoon 1, S B Kritchevsky 1
PMCID: PMC2349967  PMID: 8597666

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Das A., Wang J. H., Lien E. J. Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis. Prog Drug Res. 1994;42:133–166. doi: 10.1007/978-3-0348-7153-2_5. [DOI] [PubMed] [Google Scholar]
  2. Hertog M. G., Feskens E. J., Hollman P. C., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993 Oct 23;342(8878):1007–1011. doi: 10.1016/0140-6736(93)92876-u. [DOI] [PubMed] [Google Scholar]
  3. Hertog M. G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 1995 Feb 27;155(4):381–386. [PubMed] [Google Scholar]
  4. Jaeger A., Wälti M., Neftel K. Side effects of flavonoids in medical practice. Prog Clin Biol Res. 1988;280:379–394. [PubMed] [Google Scholar]
  5. Jha P., Flather M., Lonn E., Farkouh M., Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med. 1995 Dec 1;123(11):860–872. doi: 10.7326/0003-4819-123-11-199512010-00009. [DOI] [PubMed] [Google Scholar]
  6. Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996 Feb 24;312(7029):478–481. doi: 10.1136/bmj.312.7029.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lin J. L., Ho Y. S. Flavonoid-induced acute nephropathy. Am J Kidney Dis. 1994 Mar;23(3):433–440. doi: 10.1016/s0272-6386(12)81008-0. [DOI] [PubMed] [Google Scholar]
  8. Myara I., Pico I., Vedie B., Moatti N. A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids. J Pharmacol Toxicol Methods. 1993 Oct;30(2):69–73. doi: 10.1016/1056-8719(93)90009-4. [DOI] [PubMed] [Google Scholar]
  9. Salonen J. T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J. L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992 Apr 11;339(8798):883–887. doi: 10.1016/0140-6736(92)90926-t. [DOI] [PubMed] [Google Scholar]
  10. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES